THC & Politics
March 15, 2026
Massachusetts' cannabis industry is drowning in debt, and the question of whether government should throw it a lifeline is splitting regulators, lawmakers, and industry players themselves. The numbers tell a cautionary tale: oversaturation has cratered prices from over $400 per ounce in 2020 to $114.82 in January 2026, even as the state harvested 113 million cannabis plants in December alone compared to just 10 million five years earlier. 💰 MONEY MOVES The industry still generated $289 million in taxes last year and employs 21,000 people, but pot shops, cultivators, and associated companies increasingly can't pay their lenders, taxes, or suppliers. The real problem isn't the plants themselves—it's the distorted market created by federal prohibition. Cannabis businesses face rules that don't apply to other industries: they make "impact" payments to municipalities, pay higher federal taxes because the feds still consider them illegal, can't access traditional bank loans, and operate under strict security and tracking regulations that drive up costs. Growers and shop owners were betting on a gold rush that simply hasn't materialized because Massachusetts residents are consuming less marijuana than entrepreneurs optimistically projected. That's actually not a bad outcome from a public health perspective, and lower prices benefit those who do choose to use. The question is whether intervention is justified when the market itself is warped by federal policy.
Meanwhile, in Missouri, state lawmakers just approved new cannabis rules aimed at preventing predatory contracts in the social-equity microbusiness program, but they stopped short of banning people tied to revoked licenses from holding future licenses. The Joint Committee on Administrative Rules backed a shift that will move regulators' ownership review to *before* licenses are issued rather than after—a change meant to prevent another wave of license revocations. Of the 105 microbusiness licenses issued since the program launched in 2023, 35 have already been revoked. Missouri Division of Cannabis Regulation director Amy Moore testified that the pattern is clear: "Third parties used eligible individuals, names and circumstances to attempt to acquire licenses for themselves." The investigation found instances where winners of licenses "very clearly, through review of agreements and interviews, were not owning and operating the license." The program was designed to boost opportunities for people in disadvantaged communities most impacted by the war on drugs, but predatory operators have exploited it systematically. The new rules tighten oversight, though lawmakers stripped out the language that would have barred denied or revoked applicants' agents and representatives from future control—Republican Rep. Ben Keathley said it was too broad.
Beyond the market mechanics, a separate debate is unfolding over medical conscience laws. Eight states—Kentucky, Missouri, New Hampshire, Oklahoma, Rhode Island, South Carolina, Utah, and West Virginia—have introduced expanded medical conscience legislation that would let doctors, nurses, hospitals, and insurers refuse care on religious or moral grounds. The list of services they could refuse is expanding well beyond abortion to include contraception, fertility services, childhood vaccines, and notably, medical marijuana. Supporters, including the conservative Sutherland Institute, argue this protects providers from being forced to participate in practices that violate deeply held beliefs. But critics warn the language is so broad it would let providers deny just about anything, fundamentally undermining patients' access to comprehensive care. The debate crystallized in Tennessee, which already has an expanded conscience law, when a woman was prepped for sterilization surgery—already hooked up to an IV—before hospital staff canceled the procedure, citing the hospital's duty to "protect her sacred fertility." 🤔 THINK ABOUT IT When medical conscience laws expand to include medical marijuana, providers in states with conscience protections could theoretically refuse to recommend or discuss cannabis therapeutics with patients seeking alternatives to opioids—even though zero Americans have ever died of a cannabis overdose, while prescription opioids kill more than 16,000 annually.
Sources
